Higher Rx charges in England among factors spurring demand for OTC medicines
A rise in prescription charges in England, the National Health service budget squeeze, the government’s promotion of self-care and self-medication, and the switching of some prescription medicines to over-the-counter (OTC) products have led to an increase in demand for OTC pharmaceuticals.
According to OTC Pharmaceuticals, a new Market Update published by market intelligence provider Key Note, retail sales of OTC pharmaceuticals grew by 6.7% in the year ending in February 2015. Analgesics comprise the largest sector within the OTC pharmaceuticals market, accounting for 21.5% of the total, followed by skincare treatment products (19.4%), cough, cold and sore-throat remedies (17.8%) and gastro-intestinal remedies (9.6%).
Highest sales for adult analgesics
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze